Literature DB >> 1764164

2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.

S Erber1, R Ringshandl, E von Angerer.   

Abstract

A number of 2-(4-hydroxyphenyl)benzo[b]furans with a hydroxy group in position 5 or 6 and a short alkyl group at C-3 were synthesized from appropriate 1,2-diarylethanones and studied for their estrogen receptor affinity. The relative binding affinities in the 5-hydroxy series were higher than those of 6-hydroxy derivatives by a factor of 10. The trifluoroethyl and the propyl derivatives displayed the best relative binding affinity values (33 (15a) and 20 (12a); 17 beta-estradiol = 100). All benzofurans with high receptor affinity were tested for specific cytostatic activity using hormone-sensitive human MCF-7 mammary tumor cells and hormone-independent MDA-MB 231 cells. 5-Hydroxy derivatives with an ethyl (11a) or a propyl (12a) group completely inhibited the growth of MCF-7 cells at a concentration of 5 microM (tamoxifen: 70% inhibition). Since the cytostatic activity in MDA-MB 231 cells was much lower, an anti-tumor effect mainly mediated by the estrogen receptor has to be assumed. In the mouse uterine weight test these compounds gave rise to a partial estrogen antagonism which may account for the inhibitory effect in estrogen-sensitive tumor cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764164

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  2 in total

1.  Synthesis and preliminary evaluation of the antimicrobial activity of selected 3-benzofurancarboxylic acid derivatives.

Authors:  Jerzy Kossakowski; Mariola Krawiecka; Bozena Kuran; Joanna Stefańska; Irena Wolska
Journal:  Molecules       Date:  2010-07-06       Impact factor: 4.411

2.  Palladium-catalyzed cross-coupling reaction of alkenyl aluminums with 2-bromobenzo[b]furans.

Authors:  Chang Wen; Xin Jiang; Kun Wu; Ruiqiang Luo; Qinghan Li
Journal:  RSC Adv       Date:  2020-05-22       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.